Search

Your search keyword '"Dumaz, Nicolas"' showing total 245 results

Search Constraints

Start Over You searched for: Author "Dumaz, Nicolas" Remove constraint Author: "Dumaz, Nicolas"
245 results on '"Dumaz, Nicolas"'

Search Results

7. Combined PDE4+MEK inhibition shows antiproliferative effects in NRAS Q61 mutated melanoma preclinical models

8. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network

15. Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2.

16. Supplementary Figure Legends 1-2 from Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of HRAS, TP53, and TGFBR1

17. Supplementary Figure from Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma

18. Supplementary Data from Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma

19. Supplementary Figure 1 from Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of HRAS, TP53, and TGFBR1

20. Supplementary Figure 2 from Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of HRAS, TP53, and TGFBR1

27. PARKIN Inactivation Links Parkinson’s Disease to Melanoma

28. Supplementary Figures for Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction

29. Supplementary Materials and Methods for Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction

30. Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction

32. Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma

36. Fgf2 induces resistance to nilotinib through mapk pathway activation in kit mutated melanoma

37. Genetic variation at KIT locus may predispose to melanoma

41. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

43. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

45. Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care

47. A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

50. PDE4D is a therapeutic target in melanoma

Catalog

Books, media, physical & digital resources